Cellular and Molecular Mechanisms of Breast Cancer

A special issue of Cells (ISSN 2073-4409). This special issue belongs to the section "Cellular Pathology".

Deadline for manuscript submissions: 31 August 2026 | Viewed by 21

Special Issue Editors


E-Mail
Guest Editor
Medical Oncology and Breast Unit, University Hospital of Parma, 43126 Parma, Italy
Interests: breast cancer; brain tumors; precision medicine; target therapy

E-Mail Website
Guest Editor
Medical Oncology and Breast Unit, University Hospital of Parma, 43126 Parma, Italy
Interests: breast cancer; homologous recombination deficiency; precision medicine; target therapy

Special Issue Information

Dear Colleagues,

Breast cancer represents a paradigmatic example of tumour complexity, arising from the dynamic integration of cellular and molecular alterations that govern disease initiation, progression, and therapeutic response. Advances in molecular oncology have revealed how dysregulated signalling pathways—including estrogen receptor and HER2-driven networks, together with downstream PI3K/AKT/mTOR, MAPK, and developmental signalling cascades—orchestrate aberrant cell growth, survival, and metastatic dissemination across distinct breast cancer subtypes. These pathways do not operate in isolation; rather, their extensive cross-talk, combined with genomic aberrations and transcriptional reprogramming, drives tumour plasticity, subtype-specific behaviour, and variable responses to targeted therapies.

Beyond genetic alterations, epigenetic regulation through DNA methylation, histone modifications, and non-coding RNAs profoundly influences tumour adaptability, and the development of therapeutic resistance. In parallel, metabolic reprogramming enables breast cancer cells to cope with fluctuating nutrient availability and treatment-induced stress. The tumour microenvironment, comprising immune cells, cancer-associated fibroblasts, endothelial cells, and extracellular matrix components, actively shapes tumour evolution by promoting immune evasion, angiogenesis, and disease progression.

Recent advances in single-cell and spatial profiling technologies, integrated with multi-omics approaches, have markedly improved the characterization of intratumoral heterogeneity and clonal dynamics. By integrating insights into signalling pathways, molecular regulation, and microenvironmental interactions, this Special Issue aims to highlight emerging concepts and innovative strategies to advance precision oncology in breast cancer.

Dr. Chiara Tommasi
Dr. Benedetta Pellegrino
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • breast caner
  • precision medicine
  • target therapy
  • homologous recombination deficiency
  • acquired mutations
  • germinal mutations
  • resistance to cancer therapy
  • tumoral heterogeneity

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop